| __timestamp | PTC Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 5078000000 |
| Thursday, January 1, 2015 | 82080000 | 4717000000 |
| Friday, January 1, 2016 | 97130000 | 5096000000 |
| Sunday, January 1, 2017 | 121271000 | 4986000000 |
| Monday, January 1, 2018 | 153548000 | 4214000000 |
| Tuesday, January 1, 2019 | 202541000 | 3806000000 |
| Wednesday, January 1, 2020 | 245164000 | 3671000000 |
| Friday, January 1, 2021 | 285773000 | 3528000000 |
| Saturday, January 1, 2022 | 325998000 | 3445000000 |
| Sunday, January 1, 2023 | 332540000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Teva Pharmaceutical Industries Limited and PTC Therapeutics, Inc. have taken different paths in optimizing these costs.
From 2014 to 2023, Teva's SG&A expenses have seen a significant reduction of approximately 31%, from $5.08 billion to $3.50 billion. This reflects a strategic focus on cost efficiency. In contrast, PTC Therapeutics has experienced a sevenfold increase in SG&A expenses, from $44.82 million to $332.54 million, indicating aggressive expansion and investment in growth.
While Teva's cost-cutting measures highlight a mature company's focus on efficiency, PTC's rising expenses suggest a growth-oriented strategy. Investors and analysts should consider these trends when evaluating the financial health and strategic direction of these companies.
Eli Lilly and Company and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Pfizer Inc. and PTC Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amgen Inc. and PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of GSK plc and Teva Pharmaceutical Industries Limited
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited and Merus N.V.: SG&A Spending Patterns Compared
Teva Pharmaceutical Industries Limited or Agios Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Catalent, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Geron Corporation Trends and Insights
PTC Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?